Actavis: No apologies for seeking Alzheimer's drug profits
Monday, April 13, 2015 - 18:30
in Health & Medicine
NEW YORK (AP) -- A lawyer for the Irish manufacturer of an Alzheimer's drug is urging a U.S. appeals court to let it replace a two-pill daily regimen with a single-dose drug even if it cheats generic drugmakers of profits....